Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
Ghent University · Karolinska Institutet · +21 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,451
total citations
- FWCI
- 100.69
- Percentile
- 100%
- References
- 32
Citations per year
Authors
34Topics & keywords
Topics
Keywords
- Medicine
- Dupilumab
- Nasal polyps
- Placebo
- Internal medicine
- Placebo-controlled study
- Sinusitis
- Clinical endpoint
UN Sustainable Development Goals
- No poverty
No related works found for this paper.